Abstract
Major advances in cataract extraction techniques and instrumentation have occurred over the past decade. Smaller incisions, more efficient phacoemulsifiers, and decreased surgical times are a few of the changes that have helped to alleviate postoperative inflammation, but postoperative inflammation continues to be a cause of patient discomfort; delayed recovery; and, in some cases, suboptimal visual results secondary to cystoid macular edema. This article reviews the most recent literature regarding the control of intraocular inflammation associated with cataract surgery.
MeSH terms
-
Anti-Inflammatory Agents, Non-Steroidal / administration & dosage
-
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
-
Cataract Extraction / adverse effects*
-
Dexamethasone / administration & dosage*
-
Dexamethasone / therapeutic use
-
Drug Delivery Systems*
-
Glucocorticoids / administration & dosage*
-
Glucocorticoids / therapeutic use
-
Humans
-
Lens Implantation, Intraocular
-
Ophthalmic Solutions / administration & dosage
-
Ophthalmic Solutions / therapeutic use
-
Uveitis, Anterior / etiology
-
Uveitis, Anterior / prevention & control*
Substances
-
Anti-Inflammatory Agents, Non-Steroidal
-
Glucocorticoids
-
Ophthalmic Solutions
-
Dexamethasone